Exemption of clinical samples applies based on aggregate factory clearances, including loan licensee production, subject to notification conditions. The exemption to clinical samples under Notification No. 48/77 is available for clearances made from a factory by a manufacturer after taking into consideration the aggregate value of clearances of P or P medicines from that factory in the preceding month, irrespective of whether they are manufactured on the manufacturer's own account or on account of any loan licensee, subject to the conditions prescribed in the notification.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Exemption of clinical samples applies based on aggregate factory clearances, including loan licensee production, subject to notification conditions.
The exemption to clinical samples under Notification No. 48/77 is available for clearances made from a factory by a manufacturer after taking into consideration the aggregate value of clearances of P or P medicines from that factory in the preceding month, irrespective of whether they are manufactured on the manufacturer's own account or on account of any loan licensee, subject to the conditions prescribed in the notification.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.